Erez Meltzer - 18 Mar 2026 Form 3 Insider Report for Nano-X Imaging Ltd. (NNOX)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 11:31:23 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marina Gofman Feler, attorney-in-fact

Key filing fact

Erez Meltzer filed Form 3 for Nano-X Imaging Ltd. (NNOX) on 18 Mar 2026.

Key facts

  • This page summarizes Erez Meltzer's Form 3 filing for Nano-X Imaging Ltd. (NNOX).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 11:31.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001371973 Primary reporting owner

Meltzer Erez

Relationship
Chief Executive Officer, Director
Address
C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL
Signature
/s/ Marina Gofman Feler, attorney-in-fact
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NNOX holding

Ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
60,584
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary shares
Underlying amount
40,234
Exercise price
$2.21
Footnotes
F1
NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary shares
Underlying amount
300,000
Exercise price
$23.84
Footnotes
F2
NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary shares
Underlying amount
150,000
Exercise price
$11.52
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.

Footnote F2

The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.

Footnote F3

The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).

SEC remarks

Exhibit 24.1 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .